Wang, P.; Wang, Z.; Jin, X.; Zhang, M.; Shen, M.; Li, D.
Oral Sulforaphane Intervention Protects Against Diabetic Cardiomyopathy in db/db Mice: Focus on Cardiac Lipotoxicity and Substrate Metabolism. Antioxidants 2025, 14, 603.
https://doi.org/10.3390/antiox14050603
AMA Style
Wang P, Wang Z, Jin X, Zhang M, Shen M, Li D.
Oral Sulforaphane Intervention Protects Against Diabetic Cardiomyopathy in db/db Mice: Focus on Cardiac Lipotoxicity and Substrate Metabolism. Antioxidants. 2025; 14(5):603.
https://doi.org/10.3390/antiox14050603
Chicago/Turabian Style
Wang, Pan, Ziling Wang, Xinyuan Jin, Mengdi Zhang, Mengfan Shen, and Dan Li.
2025. "Oral Sulforaphane Intervention Protects Against Diabetic Cardiomyopathy in db/db Mice: Focus on Cardiac Lipotoxicity and Substrate Metabolism" Antioxidants 14, no. 5: 603.
https://doi.org/10.3390/antiox14050603
APA Style
Wang, P., Wang, Z., Jin, X., Zhang, M., Shen, M., & Li, D.
(2025). Oral Sulforaphane Intervention Protects Against Diabetic Cardiomyopathy in db/db Mice: Focus on Cardiac Lipotoxicity and Substrate Metabolism. Antioxidants, 14(5), 603.
https://doi.org/10.3390/antiox14050603